MPM Oncology Impact Management »

Fulcrum Therapeutics shares owned by MPM Oncology Impact Management

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by MPM Oncology Impact Management from 13F filings

Historical chart of MPM Oncology Impact Management investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by MPM Oncology Impact Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by MPM Oncology Impact Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $11M 1.1M 9.44

More positions owned by MPM Oncology Impact Management

Cullinan Oncology Common (CGEM)
Geron Corporation Common (GERN)
Iovance Biotherapeutics Common (IOVA)
Zentalis Pharmaceuticals Common (ZNTL)
iTeos Therapeutics Common (ITOS)
Sutro Biopharma Common (STRO)
Crinetics Pharmaceuticals Common (CRNX)
Olema Pharmaceuticals Common (OLMA)
Madrigal Pharmaceuticals Common (MDGL)
Natera Common (NTRA)
Werewolf Therapeutics Common (HOWL)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Avadel Pharmaceuticals Sponsored ADR (AVDL)
Insmed Incorporated Common (INSM)
ALX Oncology Holdings Common (ALXO)

View all positions for MPM Oncology Impact Management

Top funds holding Fulcrum Therapeutics

RA Capital Management
FMR
Cowen And Company
Suvretta Capital Management
Vanguard Group
Trv Gp Iv
Caption Management
BlackRock
Citadel Advisors
Dimensional Fund Advisors
Morgan Stanley
Leucadia National Corporation
MPM Oncology Impact Management
Adage Capital Partners GP
Logos Global Management

View all funds holding Fulcrum Therapeutics